Insurance coverage for GLP-1 weight loss medications varies by plan, indication, and dose
Even with steady progress, some areas may look loose because the supporting structures beneath the skin have changed, and some people report facial skin that appears more aged after weight loss
VLEKT refers to a structured protocol providing less than 800 kcal per day, aimed at promoting rapid weight loss in individuals with overweight or obesity
Despite advances in antifungal monotherapy and combination strategies, critical challenges remain, such as overcoming the escalating drug resistance, optimizing individualized therapeutic regimens tailored to diverse patient populations, and improving long-term treatment efficacy to reduce recurrence and disease progression
The main reason for this difference lies in the disparity between preclinical research and clinical research, that is, the contradiction that GLP-1 receptor agonists show muscle-protective effects in animal models but are accompanied by fat-free body weight loss in humans
That said, the wide availability of inexpensive fitness trackers makes monitoring easy enough that there is little reason not to do it